Starvation stress attenuates the miRNA-target interaction in suppressing breast cancer cell proliferation

Jinhui Lü1, Chuyi Zhang1, Junyi Han2

  • 1Research Center for Translational Medicine, Tongji University School of Medicine, 150 Jimo Road, Shanghai, 200120, China.

BMC Cancer
|July 8, 2020
PubMed
Abstract

Insights

Starvation stress weakens microRNA-221/222 (miR-221/222) binding to p27 in breast cancer cells, inhibiting proliferation. This occurs because starvation reduces Ago2, a key protein in microRNA function.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Limited metabolic substrates can inhibit cancer cell growth.
  • MicroRNAs (miRNAs) regulate gene expression; miR-221/222 and p27 are implicated in breast cancer progression.

Purpose of the Study:

  • To investigate how starvation-induced stress affects miRNA-mRNA interactions in breast cancer cells.
  • To elucidate the mechanisms by which nutrient deprivation suppresses cancer cell proliferation.

Main Methods:

  • Studied miRNA-mRNA interactions in MDA-MB-231 breast cancer cells under starvation.
  • Manipulated miR-221/222 levels and Ago2 expression.
  • Analyzed interactions between miR-17-5p/CyclinD1 and miR-155/Socs1.

Main Results:

  • Starvation attenuated the miR-221/222-p27 interaction, increasing p27 expression and suppressing proliferation.
  • Reduced Ago2 expression under starvation impaired miRNA-target mRNA interactions.
  • Exogenous Ago2 addition restored miR-221/222-p27 interaction during starvation.

Conclusions:

  • Starvation-induced stress weakens miR-221/222 and p27 interaction in breast cancer cells.
  • This study reveals a novel mechanism for nutrient suppression of cancer cell growth.
  • Findings support developing new therapeutic strategies for breast cancer targeting nutrient access.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K